Business Development Senior Specialist at IQVIA

Tokyo, Japan

IQVIA Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Life Sciences, PharmaceuticalsIndustries

Requirements

  • 3+ years of experience in enterprise software/service sales
  • Understanding of industry trends and product updates
  • Experience in problem-solving and solution proposal development (experience in resolving client challenges and proposing technological solutions)
  • Ability to think strategically and develop visions for the future, and lead stakeholders/teams to achieve those visions
  • Native Japanese, Business English reading and writing skills (Business level preferred)

Responsibilities

  • Build and maintain relationships with key stakeholders, including business, IT, and C-level executives
  • Manage the end-to-end sales process
  • Generate a consistent sales pipeline through industry trend analysis, client-specific issue gathering, and promotion
  • Collaborate with experts in various fields and delivery/service teams to implement optimal solutions and close deals

Skills

enterprise software sales
sales pipeline management
stakeholder relationship management
strategic thinking
problem solving
Japanese
Business English
healthcare industry knowledge

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI